August 04, 2020
Graduate student Diana Aguilar Gómez tells the story of Joana Rocha, a visiting scholar in the Rasmus Nielsen lab who ventured into the Sahara Desert to study the genetic adaptations that help desert foxes thrive in extreme environments.
July 30, 2020
Although Jennifer Doudna’s CRISPR-Cas9 has become the go-to genome editor for both basic research and gene therapy, it has spawned other potentially powerful DNA manipulation tools that could help fix genetic mutations.
July 23, 2020
Wen Zhu, a postdoctoral researcher in the Klinman Lab at QB3-Berkeley, explores the key steps in PQQ biogenesis aiming to unlock PQQ’s potential for health benefits.
July 16, 2020
While the DNA-cutting proteins central to Jennifer Doudna’s CRISPR-Cas9 and related gene-editing tools originally came from bacteria, a newfound variety of Cas proteins apparently evolved in viruses that infect bacteria.
July 14, 2020
A team of researchers from Jennifer Doudna’s Innovative Genomics Institute (IGI) are using CRISPR genome editing to alter cassava, a worldwide staple crop that naturally produces the precursor of cyanide.
July 09, 2020
By applying ideas from theoretical physics, researchers are starting to develop a unified understanding of how genes are regulated.
July 07, 2020
Professor David Schaffer has been selected to serve as the next director of Berkeley’s California Institute for Quantitative Biosciences (QB3-Berkeley)
July 07, 2020
In early March, YourChoice Therapeutics CEO Akash Bakshi was typing out his investor update when he tucked in a question at the bottom. His company’s progress toward using niclosamide, a…